0000899243-21-007771.txt : 20210223 0000899243-21-007771.hdr.sgml : 20210223 20210223141413 ACCESSION NUMBER: 0000899243-21-007771 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210221 FILED AS OF DATE: 20210223 DATE AS OF CHANGE: 20210223 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Barclay Alec CENTRAL INDEX KEY: 0001734339 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36571 FILM NUMBER: 21664558 MAIL ADDRESS: STREET 1: 101 HARTWELL AVE. CITY: LEXINGTON STATE: MA ZIP: 02421 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: T2 Biosystems, Inc. CENTRAL INDEX KEY: 0001492674 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 204827488 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 101 HARTWELL AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 781-457-1200 MAIL ADDRESS: STREET 1: 101 HARTWELL AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-02-21 0 0001492674 T2 Biosystems, Inc. TTOO 0001734339 Barclay Alec 101 HARTWELL AVENUE LEXINGTON MA 02421 0 1 0 0 Chief Operations Officer Common Stock 2021-02-21 4 M 0 10000 A 72527 D Common Stock 2021-02-23 4 S 0 7280 2.06 D 65247 D Restricted Stock Units 2021-02-21 4 M 0 10000 0.00 D Common Stock 10000 10000 D Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Includes 16,233 shares acquired under the Issuer's employee stock purchase plan on November 15, 2020. The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 12, 2018. On February 21, 2019 the reporting person was granted 30,000 RSU's that vest in three equal annual installments beginning on February 21, 2020. /s/ John Sprague, Attorney-in-fact 2021-02-23